Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Colorcon
Novartis
Medtronic
Queensland Health
Moodys
Federal Trade Commission
Chubb
US Army
AstraZeneca

Generated: August 18, 2017

DrugPatentWatch Database Preview

Akorn Company Profile

« Back to Dashboard

What is the competitive landscape for AKORN, and what generic alternatives to AKORN drugs are available?

AKORN has one hundred and fifty-six approved drugs.

There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.

There are two patent family members on AKORN drugs in two countries.

Summary for Applicant: Akorn

Patents:1
Tradenames:124
Ingredients:113
NDAs:156
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
KETOTIFEN FUMARATE
ketotifen fumarate
SOLUTION/DROPS;OPHTHALMIC077958-001Jul 26, 2007OTCNoNo► Subscribe► Subscribe► Subscribe
Akorn
PYRAZINAMIDE
pyrazinamide
TABLET;ORAL081319-001Jun 30, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
GENTAMICIN SULFATE
gentamicin sulfate
SOLUTION/DROPS;OPHTHALMIC062635-001Jan 8, 1987ATRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065305-002Jan 11, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
LEVOFLOXACIN
levofloxacin
SOLUTION/DROPS;OPHTHALMIC090268-001Dec 20, 2010ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Akorn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Akorn
SUFENTA PRESERVATIVE FREE
sufentanil citrate
INJECTABLE;INJECTION019050-001May 4, 1984► Subscribe► Subscribe
Akorn
ALFENTA
alfentanil hydrochloride
INJECTABLE;INJECTION019353-001Dec 29, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Akorn Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2008014036► Subscribe
European Patent Office2043601► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Akorn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB95/010United Kingdom► SubscribePRODUCT NAME: 2-N-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL) METHYL) -5-(HYDROXYMETHYL) IMIDAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT; REGISTERED: SE 12209 19940902; UK 0025/0324 19941215; UK 0025/0336 19941215
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
923Luxembourg► SubscribePRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
1273292/01Switzerland► SubscribePRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC 58751 28.05.2009
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Teva
AstraZeneca
US Army
Johnson and Johnson
Harvard Business School
Healthtrust
Queensland Health
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot